CHINESE JOURNAL OF PARASITOLOGY AND PARASITIC DISEASES ›› 2018, Vol. 36 ›› Issue (5): 460-464.

• Orginal Article论著 • Previous Articles     Next Articles

Regulations of IL-9 by the TGF-β/Smads signaling pathway in human Echinococcus granulosus infection

Nan-nan PANG1, Meng-ting AN2, Feng-bo ZHANG1, Xiao ZHAO2, Fang YAN1, Jian-bing DING1,2,*()   

  1. 1 The First Affiliated Hospital of Xinjiang Medical University, Urumqi 830011, China
    2 Basic Medical College of Xinjiang Medical University, Urumqi 830011, China
  • Received:2018-01-29 Online:2018-10-30 Published:2018-11-13
  • Contact: Jian-bing DING E-mail:djbing002@163.com
  • Supported by:
    Supported by the National Natural Science Foundation of China (No. 81460307, No. 81660343), Research and Innovation Project Grants of Postgraduate Students in Xinjiang (No. XJGRI2017092) and Innovation Project of Xinjiang Medical University (No. CXCY2017001)

Abstract:

Objective To examine mRNA expression of TGF-β, Smad3, Smad7, PU.1 and Interleukin-9 (IL-9) in livers of patients with cystic echinococcosis, in order to explore the regulations of Th9 cells by the TGF-β/Smad signaling in Echinococcus granulosus infection. Methods The liver mononuclear cells were isolated from liver tissues obtained during surgery from 30 patients with cystic hydatid disease and 20 patients with hepatic hemangioma (control group) in the First Affiliated Hospital of Xinjiang Medical University using the Percoll method. Real-time fluorescent quantitative PCR was performed to detect the mRNA expression of TGF-β, Smad3, Smad7, PU.1 and IL-9 in the mononuclear cells. The relationship between Smad3 mRNA expression and PU.1 mRNA expression was assessed by Spearman correlation analysis. The Smad3 inhibitor SIS3 or PBS was added to the mononuclear cells of the infected group, then PU.1 and IL-9 mRNA expression were determined by real-time fluorescent quantitative PCR, and IL-9 level in the supernatant of cell culture was assessed by ELISA. Results The relative mRNA expression of TGF-β, Smad3, PU.1 and IL-9 in CE patients were 2.55 ± 1.32, 2.26 ± 1.35, 1.71 ± 0.66 and 1.67 ± 0.75, respectively, all significantly higher than those in the control group (1.54 ± 0.76, 1.34 ± 0.51, 1.27 ± 0.62 and 1.01 ± 0.50, P < 0.05 or 0.01). The relative mRNA expression of Smad7 in CE patients (0.49 ± 0.37) was significantly lower than that in the control group (0.88 ± 0.50; P < 0.01). The Smad3 mRNA expression and PU.1 mRNA expression were positively correlated (r = 0.397, P < 0.05). After blocking the TGF-β/Smad signaling pathway by SIS3, the expression of PU.1 and IL-9 mRNA in liver mononuclear cells (1.00 ± 0.57, 0.85 ± 0.50) both decreased compared with the PBS treatment (1.46 ± 0.64, 1.32 ± 0.72) (P < 0.01). ELISA results showed that the IL-9 level in the supernatant of cell culture [(128.45 ± 41.97) pg/ml] also reduced compared with the PBS treatment [(166.64 ± 57.90) pg/ml; P < 0.05]. Conclusion The expression of TGF-β, Smad2, Smad3, PU.1 and IL-9 up-regulated in patients with cystic hydatid disease and the TGF-β/Smad pathway may regulate the expression of IL-9 after Echinococcus granulosus infection.

Key words: Echinococcus granulosus, Infection, TGF-β/Smad signal pathway;, PU.1, IL-9

CLC Number: